HHS reports increase in buprenorphine providers, naloxone prescriptions
The number of health care providers with waivers to prescribe buprenorphine for opioid use disorder increased 19% between October 2021 and September 2022 to 132,005, the Department of Health and Human Services announced today. HHS last April issued revised practice guidelines for administering buprenorphine to treat OUD, which eased requirements for clinicians to obtain a waiver to treat OUD patients with buprenorphine. According to HHS, pharmacy-filled prescriptions for the overdose reversal drug naloxone also increased 37% over the period, from a three-month average of 109,414 prescriptions in October 2021 to 150,213 in August 2022.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services Dec. 23 introduced a new drug pricing model for Medicare Part D and Medicaid beneficiaries. The Better…
Headline
Thank you for listening to Advancing Health! As we close out 2025, we’re excited to share highlights from two impactful episodes that sparked dialogue around…
Headline
The Centers for Medicare & Medicaid Services Dec. 19 issued two proposed rules for implementing alternative drug pricing models. The first proposed…
Headline
The AHA Dec. 19 submitted comments on the Department of Homeland Security’s proposed rule regarding the Public Charge Ground of Inadmissibility, urging the…
Headline
The White House announced Dec. 19 that it reached most-favored-nation deals with nine pharmaceutical companies, aligning their drug prices with the lowest paid…
Headline
The House Dec. 17 passed the Lower Health Care Premiums for All Americans Act (H.R. 6703), legislation to expand association health plans, increase…